Top Markets
#1 Black Phoenix Black Phoenix +367.56%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +41.87%
#6 Acurast Acurast +35.56%
#7 BasedHype BasedHype +29.98%
#8 GoPlus Security GoPlus Security +22.00%
#9 Cryptopia Cryptopia +21.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +21.15%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Classement en actions #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Prix de l'action
$0.04082105
Dernière synchronisation: 2024-08-12
Capitalisation boursière
$39.09K
Changement (1 jour)
-19.83%
Changement (1 an)
0.00%
Pays
GB
Échange Destiny Pharma plc (DEST)

Catégorie

Healthcare
Revenus pour Destiny Pharma plc (DEST)
Revenus en Dec 2023 TTM : $1.06M
Selon les derniers rapports financiers de Destiny Pharma plc, le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.06M. En 2022, l'entreprise a réalisé un chiffre d'affaires de $186.91K une augmentation par rapport à le chiffre d'affaires de l'année 2021, qui était de $182.56K. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Destiny Pharma plc de 2013 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $1.06M 0.00%
2023 $1.06M 466.34%
2022 $186.91K 2.39%
2021 $182.56K 972.50%
2020 $17.02K -95.80%
2019 $405.66K 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 1,192,485.48%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 568,715.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 955,040.28%
BE